Paper Details

Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Metformin in the Management of Fibrocystic Breast Disease: A Placebo-Controlled Randomized Clinical Trial

Akram Ghahghaei Nezamabadi

Akram Ghahghaei Nezamabadi

Assistant Professor of Gynecology Oncology

Department Obstetrics and Gynecology

School of Medicine

Arash Hospital

Tehran University of Medical Sciences

Related Documents

1. The Impact of Adjunctive Metformin to Progesterone for the Treatment of Non-Atypical Endometrial Hyperplasia in a Randomized Fashion, a Placebo-Controlled, Double Blind Clinical Trial, Journal of Gynecology Obstetrics and Human Reproduction (2021)

All Documents

1. Comparison of Cytopathologic Findings in Patients With Negative Pap Test and Positive High-Risk Hpv Infection Among Three Groups, Archives of Gynecology and Obstetrics (2022)

2. An Ovarian Hydatid Disease Imitating Ovarian Neoplasm: A Case Report, Journal of Gynecologic Surgery (2021)

3. Evaluation of Diagnostic Accuracy of Rmi and Roma Indices in Comparison to He4 and Ca125 Parameters for Estimating the Risk of Malignancy of Adnexal Masses, Tehran University Medical Journal (2021)

4. Ovarian Mature Cystic Teratoma With Malignant Transformation: Two Case Reports, Journal of Medical Case Reports (2021)

5. The Impact of Adjunctive Metformin to Progesterone for the Treatment of Non-Atypical Endometrial Hyperplasia in a Randomized Fashion, a Placebo-Controlled, Double Blind Clinical Trial, Journal of Gynecology Obstetrics and Human Reproduction (2021)

6. Impact of Diabetes Mellitus on Epithelial Ovarian Cancer Survival, BMC Cancer (2018)

7. Preoperative Monocyte Count As a Mirror of Tumor Characteristics and Likelihood of Recurrence in Endometrial Carcinoma Cases, Asian Pacific Journal of Cancer Prevention (2018)

8. Primary Immature Teratoma of the Uterus With Peritoneal and Lymph Node Involvement, Case Report, Journal of Obstetrics and Gynaecology (2017)

9. Cancer-Testis Antigens: A Novel Group of Tumor Biomarkers in Ovarian Cancers, International Journal of Cancer Management (2016)